339 related articles for article (PubMed ID: 26780348)
1. Sex differences in the subjective effects of oral Δ
Fogel JS; Kelly TH; Westgate PM; Lile JA
Pharmacol Biochem Behav; 2017 Jan; 152():44-51. PubMed ID: 26780348
[TBL] [Abstract][Full Text] [Related]
2. Separate and combined effects of the GABAA positive allosteric modulator diazepam and Δ⁹-THC in humans discriminating Δ⁹-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2014 Oct; 143():141-8. PubMed ID: 25124305
[TBL] [Abstract][Full Text] [Related]
3. Separate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2012 Apr; 122(1-2):61-9. PubMed ID: 21975195
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in the acute effects of oral and vaporized cannabis among healthy adults.
Sholler DJ; Strickland JC; Spindle TR; Weerts EM; Vandrey R
Addict Biol; 2021 Jul; 26(4):e12968. PubMed ID: 32985064
[TBL] [Abstract][Full Text] [Related]
5. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600
[TBL] [Abstract][Full Text] [Related]
6. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.
Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM
Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107
[TBL] [Abstract][Full Text] [Related]
7. Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2012 Nov; 126(1-2):216-23. PubMed ID: 22699093
[TBL] [Abstract][Full Text] [Related]
8. An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults.
Kollins SH; Schoenfelder EN; English JS; Holdaway A; Van Voorhees E; O'Brien BR; Dew R; Chrisman AK
J Subst Abuse Treat; 2015 Jan; 48(1):96-103. PubMed ID: 25175495
[TBL] [Abstract][Full Text] [Related]
9. Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol.
Lile JA; Kelly TH; Pinsky DJ; Hays LR
Psychopharmacology (Berl); 2009 Apr; 203(2):241-50. PubMed ID: 19018520
[TBL] [Abstract][Full Text] [Related]
10. Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress.
Childs E; Lutz JA; de Wit H
Drug Alcohol Depend; 2017 Aug; 177():136-144. PubMed ID: 28599212
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in the acute effects of intravenous (IV) delta-9 tetrahydrocannabinol (THC).
Bassir Nia A; Orejarena MJ; Flynn L; Luddy C; D'Souza DC; Skosnik PD; Pittman B; Ranganathan M
Psychopharmacology (Berl); 2022 May; 239(5):1621-1628. PubMed ID: 35438304
[TBL] [Abstract][Full Text] [Related]
12. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
13. The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Δ
Boggs DL; Cortes-Briones JA; Surti T; Luddy C; Ranganathan M; Cahill JD; Sewell AR; D'Souza DC; Skosnik PD
J Psychopharmacol; 2018 Dec; 32(12):1308-1318. PubMed ID: 30255720
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects.
Pabon E; Rockwood F; Norman GJ; de Wit H
Psychophysiology; 2022 Feb; 59(2):e13955. PubMed ID: 34665890
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults.
Matheson J; Sproule B; Di Ciano P; Fares A; Le Foll B; Mann RE; Brands B
Psychopharmacology (Berl); 2020 Feb; 237(2):305-316. PubMed ID: 31637452
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers.
Lundahl LH; Greenwald MK
Drug Alcohol Depend; 2015 Apr; 149():187-93. PubMed ID: 25725933
[TBL] [Abstract][Full Text] [Related]
17. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users.
Spindle TR; Cone EJ; Goffi E; Weerts EM; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
Drug Alcohol Depend; 2020 Jun; 211():107937. PubMed ID: 32247649
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.
Wachtel SR; ElSohly MA; Ross SA; Ambre J; de Wit H
Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of THC on time perception in frequent and infrequent cannabis users.
Sewell RA; Schnakenberg A; Elander J; Radhakrishnan R; Williams A; Skosnik PD; Pittman B; Ranganathan M; D'Souza DC
Psychopharmacology (Berl); 2013 Mar; 226(2):401-13. PubMed ID: 23179965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
